The famous and rightly revered genetic technology CRISPR made headlines recently for saving a baby from a rare genetic condition. CRISPR is considered the front line of gene tech, and it’s already on ...
The Monroe County Sheriff’s Office and the Florida Department of Law Enforcement have identified two sets of human remains from separate unresolved cases — including a Hurricane Irma victim. The ...
ROCHESTER — Vyriad, a growing Rochester firm, recently raised an additional $25 million in funding to fuel its “race” to bring a new technology to market that accurately targets cancer within a ...
From talking computers to self-driving cars, here are the trends to watch. By Brian X. Chen Brian X. Chen is The Times’s lead consumer technology writer and the author of Tech Fix, a column about the ...
A startup’s ads for controversial embryo tests hit the New York City subway. One day this fall, I watched an electronic sign outside the Broadway-Lafayette subway station in Manhattan switch ...
Juanita Francisco’s son Eddie recalls that when he was 13 years old, the antibiotics he was given for an infection caused an allergic reaction in the form of severe asthma attacks. So as not to ...
The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology designed to stop the spread of malaria. The $500,000 grant to School of ...
Several round plastic containers rest on a surface, and each contains a small, striped frog. Juvenile Australian southern corroboree frogs at the University of Melbourne laboratories Credit: Tiffany ...
MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while avoiding attack from the body’s own immune defenses. This innovation could ...
CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, ...
New research has identified genetic modifications that may increase the effectiveness of immunotherapy for multiple myeloma, a difficult-to-treat blood cancer most often diagnosed in people over 65. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results